FGF‐13 was found to be significantly associated with the shorter survival and occurrence of liver metastasis in pancreatic cancer.64 This investigation identifies FGF‐13 as a novel prognostic biomarker in pancreatic cancer. Here, FGF13 is linked to familial pancreatic carcinoma.